Compass Therapeutics Inc. (CMPX)
Compass Therapeutics Statistics
Share Statistics
Compass Therapeutics has 138.28M shares outstanding. The number of shares has increased by 0.5% in one year.
| 138.28M |
| 0.5% |
| 0.5% |
| 73.68% |
| n/a |
| 4,956 |
| 0.35% |
Short Selling Information
The latest short interest is 6.91M, so 5.02% of the outstanding shares have been sold short.
| 6.91M |
| 5.02% |
| 7.1% |
| 6.91 |
Valuation Ratios
The PE ratio is -4.66 and the forward PE ratio is -3.88. Compass Therapeutics's PEG ratio is 0.82.
| -4.66 |
| -3.88 |
| 0 |
| 0.8 |
| 1.33 |
| -4.88 |
| 0.82 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Compass Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 19.73, with a Debt / Equity ratio of 0.01.
| 19.73 |
| 19.73 |
| 0.01 |
| -0.04 |
| -0.04 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,214,114.29 |
| 35 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 77.86% in the last 52 weeks. The beta is 1.22, so Compass Therapeutics's price volatility has been higher than the market average.
| 1.22 |
| 77.86% |
| 1.92 |
| 2 |
| 71 |
| 1,421,074 |
Balance Sheet
The company has 24.23M in cash and 1.73M in debt, giving a net cash position of 22.5M.
| 24.23M |
| 1.73M |
| 22.5M |
| -315.31M |
| 149.15M |
| 136.71M |
Cash Flow
In the last 12 months, operating cash flow was -40.62M and capital expenditures -30K, giving a free cash flow of -40.65M.
| -40.62M |
| -30K |
| -40.65M |
| -0.32 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
CMPX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CMPX is $8, which is 243.3% higher than the current price. The consensus rating is "Buy".
| $8 |
| 243.3% |
| Buy |
| 8 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 12.82 |
| 4 |